| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ligand Pharmaceuticals Inc (LGND) has 11 insiders with recent SEC Form 4 filings, including 1 buy and 10 sells. LGND is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 161.3K | $35.72M | - | |
| Dir | 44.0K | $9.74M | - | |
| Dir | 33.8K | $7.48M | - | |
| Dir | 32.8K | $7.25M | - | |
| Other | 30.8K | $6.82M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 5, 2024 | Sabba Stephen L | Director | Sale+OE | 1,893 | $74.30 | $140,649.90 | -6.1% | +18.8% | +56.0% | |
| Feb 28, 2024 | Espinoza Octavio45 | Chief Financial Officer | Sale+OE | 140 | $88.46 | $12,384.40 | -0.5% | +1.9% | +37.1% | |
| Sep 22, 2023 | Davis Todd C77 | Chief Executive Officer | Buy | 4,000 | $59.38 | $237,528.80 | +5.8% | +19.9% | +74.0% | |
| May 16, 2023 | Kozarich John W61 | Director | Sell | 4,444 | $77.20 | $343,080.80 | -10.4% | -13.0% | +11.2% | |
| May 10, 2023 | Sabba Stephen L | Director | Sale+OE | 6,408 | $77.13 | $494,224.69 | -19.9% | -13.5% | +11.0% | |
| May 8, 2023 | Kozarich John W61 | Director | Sale+OE | 6,408 | $76.56 | $490,627.88 | -7.0% | -14.4% | -5.5% | |
| Mar 24, 2023 | Reardon Andrew | See Remarks | Sell | 300 | $69.92 | $20,977.29 | -1.8% | +9.1% | +2.3% | |
| Dec 16, 2022 | Higgins John L66 | Director | Sell | 10,000 | $61.87 | $618,657.00 | -2.3% | +17.7% | +7.5% | |
| Nov 17, 2022 | Higgins John L66 | Chief Executive Officer | Sale+OE | 10,000 | $78.32 | $783,173.00 | -2.3% | -6.9% | -26.2% | |
| Nov 9, 2022 | Espinoza Octavio45 | Chief Financial Officer | Sell | 1,696 | $75.64 | $128,282.56 | -16.1% | -3.5% | -27.4% |